Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Jul 19 2024

· Issued by Zydus Lifesciences Limited

Filed with NSE · · 2 pages · English

Summary by 6ix AI

Zydus Lifesciences Limited has issued a press release regarding the completion of a USFDA inspection at its transdermal manufacturing site in Ahmedabad. The inspection took place over several days and concluded with two observations from the USFDA. The company expressed confidence in addressing the issues raised within the required timeline.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated July 19, 2024, titled "Stock Exchange intimation on completion of USFDA inspection attransdermal manufacturing site".

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases